H.R.5031 - Inflammatory Bowel Disease Act107th Congress (2001-2002)
|Sponsor:||Rep. Kelly, Sue W. [R-NY-19] (Introduced 06/27/2002)|
|Committees:||House - Energy and Commerce|
|Latest Action:||07/16/2002 Referred to the Subcommittee on Health.|
This bill has the status Introduced
Here are the steps for Status of Legislation:
Subject — Policy Area:
- View subjects
Summary: H.R.5031 — 107th Congress (2001-2002)All Bill Information (Except Text)
Inflammatory Bowel Disease Act - Requires the Director of the National Institute of Diabetes and Digestive and Kidney Diseases to expand activities addressing inflammatory bowel disease, emphasizing genetic, animal model, and clinical research.
Introduced in House (06/27/2002)
Requires the Director of the Centers for Disease Control and Prevention to establish a national program of prevention and epidemiology concerning such disease, addressing its prevalence and public and professional awareness.
Directs the Institute of Medicine of the National Academies of Science to study public and private insurance standards for coverage of inflammatory bowel therapies.
Directs the General Accounting Office to study problems inflammatory bowel disease patients have applying for disability insurance benefits under the Social Security Act.